Ceva retains pricing premium on euros, Grifols does without

© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Ceva retains pricing premium on euros, Grifols does without

Animals 230x150

Ceva Sante Animale launched an €818m transatlantic loan package on Monday, as it seeks to refinance the capital structure it set up in 2007. But while another transatlantic deal — $4.8bn for Spanish pharmaceuticals company Grifols — achieved the same margin on its euro and dollar tranches late last week, Ceva has retained the traditional 25bp premium on the euro debt over the dollars.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts
Gift this article